Search research articles
Contact Us
Filters
Showing results (651-660 of 818) with videos related to
Page
of 82
Sort By:
Journal of Vascular Surgery
|
January 27, 2019
A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis
Anthony J Bleyer, Vincent A Scavo, Samuel E Wilson, et al.
Journal of Translational Medicine
|
July 25, 2022
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors
Cindy A Sander, Elizabeth A Rush, Jian Shi, et al.
Oral Oncology
|
October 28, 2017
Improving margin revision: Characterization of tumor bed margins in early oral tongue cancer
Arpan V Prabhu, Charles D Sturgis, Chi Lai, et al.
Social Cognitive and Affective Neuroscience
|
June 7, 2015
Mindfulness meditation training alters stress-related amygdala resting state functional connectivity: a randomized controlled trial
Adrienne A Taren, Peter J Gianaros, Carol M Greco, et al.
Cancers
|
April 27, 2024
Th2 Cells Are Associated with Tumor Recurrence Following Radiation
Mohamed K Abdelhakiem, Riyue Bao, Phillip M Pifer, et al.
Ophthalmology
|
August 1, 2018
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16
Tiarnan D Keenan, Elvira Agrón, Amitha Domalpally, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2011
Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer
A Argiris, M V Karamouzis, R Smith, et al.
Head & Neck
|
June 26, 2020
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
Chia-Jui Yen, Naomi Kiyota, Nobuhiro Hanai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2017
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals
Gulidanna Shayan, Benjamin A Kansy, Sandra P Gibson, et al.
Clinical and Experimental Immunology
|
February 8, 2023
Tumor gene signatures that correlate with release of extracellular vesicles shape the immune landscape in head and neck squamous cell carcinoma
Isabella Kallinger, Dominique S Rubenich, Alicja Głuszko, et al.
Page
of 82
Search research articles
Search
Showing results (651-660 of 818) with videos related to
Sort By:
Page
of 82
Journal of Vascular Surgery
|
January 27, 2019
A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis
Anthony J Bleyer, Vincent A Scavo, Samuel E Wilson, et al.
Journal of Translational Medicine
|
July 25, 2022
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors
Cindy A Sander, Elizabeth A Rush, Jian Shi, et al.
Oral Oncology
|
October 28, 2017
Improving margin revision: Characterization of tumor bed margins in early oral tongue cancer
Arpan V Prabhu, Charles D Sturgis, Chi Lai, et al.
Social Cognitive and Affective Neuroscience
|
June 7, 2015
Mindfulness meditation training alters stress-related amygdala resting state functional connectivity: a randomized controlled trial
Adrienne A Taren, Peter J Gianaros, Carol M Greco, et al.
Cancers
|
April 27, 2024
Th2 Cells Are Associated with Tumor Recurrence Following Radiation
Mohamed K Abdelhakiem, Riyue Bao, Phillip M Pifer, et al.
Ophthalmology
|
August 1, 2018
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16
Tiarnan D Keenan, Elvira Agrón, Amitha Domalpally, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2011
Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer
A Argiris, M V Karamouzis, R Smith, et al.
Head & Neck
|
June 26, 2020
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
Chia-Jui Yen, Naomi Kiyota, Nobuhiro Hanai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2017
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals
Gulidanna Shayan, Benjamin A Kansy, Sandra P Gibson, et al.
Clinical and Experimental Immunology
|
February 8, 2023
Tumor gene signatures that correlate with release of extracellular vesicles shape the immune landscape in head and neck squamous cell carcinoma
Isabella Kallinger, Dominique S Rubenich, Alicja Głuszko, et al.
Page
of 82